# Lennham Pharmaceuticals, Inc. — Form D

Lennham Pharmaceuticals, Inc. of CONCORD, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-03-25. The offering totals $2.3M, of which $2.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2021-03-25
- Form: D
- Accession: 0001104659-21-041312
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $2.3M
- Amount sold: $2.3M
- Minimum investment: $50K
- Investors: 19
- Date of first sale: 2019-10-19
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-393490

## Issuer

- Name: Lennham Pharmaceuticals, Inc.
- CIK: 0001853301
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 53 MAIN STREET, CONCORD, MA, 01742
- Phone: 617 388-7171

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Benjamin D Enerson | Executive Officer | Concord, MA |
| Bradford C Sippy | Director | Concord, MA |
| Bradford C Sippy | Executive Officer | Concord, MA |
| Corey D MacGregor | Executive Officer | Concord, MA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2023-04-04](https://search.stillhousedata.com/formd/0001104659-23-041280) | D | $1.2M | $1.2M |

## More

- [CIK 1853301 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1853301&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001104659-21-041312.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.